Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE1520.00127.5 (+9.16 %)

PREV CLOSE ( ) 1392.50

OPEN PRICE ( ) 1432.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 25023

TODAY'S LOW / HIGH ( )1391.30 1528.35

52 WK LOW / HIGH ( )482.5 1675.25

NSE1503.65111.45 (+8.01 %)

PREV CLOSE( ) 1392.20

OPEN PRICE ( ) 1408.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1503.65 (713)

VOLUME 618632

TODAY'S LOW / HIGH( ) 1392.30 1529.00

52 WK LOW / HIGH ( )482 1675

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1990

Management Info

Arun Kumar - Chairman Badree Komandur - Managing Director

Registered Office

Address 201, Devavrata,Sector-17,Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022-27892924 / 3199

Email corpcomm@strides.com

Website www.strides.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

26Oct Strides Pharma Science’s arm to acquir
Strides Pharma Science’s wholly owned step-down subsidiary--Strides Phar..

25Oct Strides Pharma Science trades marginal
Strides Pharma Science is currently trading at Rs. 1535.95, up by 1.30 p..

24Oct Strides Pharma Science gets nod to inv
Strides Pharma Science has received approval for investment not exceedin..

16Oct Strides Pharma Science informs about p
Strides Pharma Science has informed that it enclosed Press Release issue..

09Oct Strides Pharma Science informs about p
Strides Pharma Science has informed that it enclosed a copy of Newspaper..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	153.08	654.91
Gross Profit	144.32	696.21
Operating Profit	865.75	3275.82
Net Sales	6099.57	21532.58

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Concord Biotech (BSE) 1997.35 (5.21%)	M.Cap ( in Cr)20895.52
Alkem Laboratories (BSE) 5601.00 (1.37%)	M.Cap ( in Cr)66968.36
AMI Organics (BSE) 2093.30 (3.41%)	M.Cap ( in Cr)8568.81
Divi's Lab (BSE) 5960.00 (1.08%)	M.Cap ( in Cr)158219.27
Shilpa Medicare (BSE) 935.80 (6.35%)	M.Cap ( in Cr)9151.27

Shareholding Pattern

	PROMOTERS	25.84%
	NON-INSTITUTION	25.83%
	MUTUAL FUNDS/UTI	10.8%
	FI/BANKS/INSURANCE	5.87%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Mfg...	2.69
Aditya Birla SL Pha...	2.12
Aditya Birla SL Spe...	2.00
Aditya Birla SL Pur...	1.90
Quant Business Cycl...	1.82
Quant Active Fund(G)	1.77
Quant Small Cap Fund(G)	1.75

Risk Disclosures on Derivatives

Smart Quotes

STRIDES PHARMA SCIENCE LTD.